[go: up one dir, main page]

AU2001237029A1 - Compositions comprising flavopiridol and their use for hiv therapy - Google Patents

Compositions comprising flavopiridol and their use for hiv therapy

Info

Publication number
AU2001237029A1
AU2001237029A1 AU2001237029A AU3702901A AU2001237029A1 AU 2001237029 A1 AU2001237029 A1 AU 2001237029A1 AU 2001237029 A AU2001237029 A AU 2001237029A AU 3702901 A AU3702901 A AU 3702901A AU 2001237029 A1 AU2001237029 A1 AU 2001237029A1
Authority
AU
Australia
Prior art keywords
flavopiridol
compositions
hiv therapy
hiv
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001237029A
Inventor
David H. Price
Adrian M. Senderowicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Iowa Research Foundation UIRF
US Department of Health and Human Services
Original Assignee
University of Iowa Research Foundation UIRF
US Department of Health and Human Services
Government of the United States of America
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Iowa Research Foundation UIRF, US Department of Health and Human Services, Government of the United States of America filed Critical University of Iowa Research Foundation UIRF
Publication of AU2001237029A1 publication Critical patent/AU2001237029A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001237029A 2000-02-15 2001-02-15 Compositions comprising flavopiridol and their use for hiv therapy Abandoned AU2001237029A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18244000P 2000-02-15 2000-02-15
US60182440 2000-02-15
PCT/US2001/004898 WO2001060367A1 (en) 2000-02-15 2001-02-15 Compositions comprising flavopiridol and their use for hiv therapy

Publications (1)

Publication Number Publication Date
AU2001237029A1 true AU2001237029A1 (en) 2001-08-27

Family

ID=22668500

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001237029A Abandoned AU2001237029A1 (en) 2000-02-15 2001-02-15 Compositions comprising flavopiridol and their use for hiv therapy

Country Status (2)

Country Link
AU (1) AU2001237029A1 (en)
WO (1) WO2001060367A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002030410A2 (en) * 2000-10-10 2002-04-18 Board Of Regents, The University Of Texas System Suppression of cyclin kinase activity for prevention and treatment of infections
DE10138912A1 (en) * 2001-08-08 2003-02-27 Medinnova Ges Med Innovationen Use of active substances for the prophylaxis and / or therapy of viral diseases as well as test system for finding such active substances

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284856A (en) * 1988-10-28 1994-02-08 Hoechst Aktiengesellschaft Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives
US5733920A (en) * 1995-10-31 1998-03-31 Mitotix, Inc. Inhibitors of cyclin dependent kinases
AU2195297A (en) * 1996-02-20 1997-09-02 Sloan-Kettering Institute For Cancer Research Combinations of pkc inhibitors and therapeutic agents for treating cancers
US5849733A (en) * 1996-05-10 1998-12-15 Bristol-Myers Squibb Co. 2-thio or 2-oxo flavopiridol analogs

Also Published As

Publication number Publication date
WO2001060367A1 (en) 2001-08-23

Similar Documents

Publication Publication Date Title
AU2001252135A1 (en) Therapeutic agents
AU2001267064A1 (en) Surgical table
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2001287299A1 (en) Benzoylpyrazols and their use as herbicides
PT1296974E (en) 2-cyanopyrrolidine derivatives and their use as medicaments
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001287023A1 (en) Plasma-derived-fibrin-based matrices and tissue
AU2002214324A1 (en) Medicinal compositions
AU2001290239A1 (en) Medicinal composition
AU2001292047A1 (en) Composition containing an azaphthalocyanine and use
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2001229439A1 (en) Bioconjugates and uses thereof
AU2001270129A1 (en) Human phosphodiesterases
AU2002227925A1 (en) Human beta-defensin-3
AU2001268653A1 (en) Combination hiv therapy including camptothecin
AU2001273903A1 (en) Therapeutic agents
AU2002234165A1 (en) Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
AU4129800A (en) Bis-benzazoles and their use as antineoplastic agents
AU4432001A (en) Trityl-type compounds and their use
AU2001255773A1 (en) Human caspase-14 compositions
AU2001237029A1 (en) Compositions comprising flavopiridol and their use for hiv therapy
AU2001262928A1 (en) Pharmaceutical compositions and their use
AU2001259564A1 (en) Pharmaceutical compositions and methods for use